New hope for millions: safer schistosomiasis treatment for toddlers tested
NCT ID NCT03640377
First seen Apr 24, 2026 · Last updated May 23, 2026 · Updated 5 times
Summary
This study tested two different doses of praziquantel (40 vs 80 mg/kg) in 354 children aged 1-4 years with schistosomiasis, a parasitic infection. The goal was to find a safe and effective dose that could cure the infection and improve growth and nutrition. The trial also looked at how often treatment should be given (every 6 or 12 months) to best control the disease in this age group.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHISTOSOMIASIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
London School of Tropical Hygiene and Medicine
London, United Kingdom
-
Medical Research Council
Entebbe, 3FC6+Q3C,, Uganda
Conditions
Explore the condition pages connected to this study.